Development of Equine Polyclonal Antibodies as a Broad-Spectrum Therapy Against SARS-CoV-2 Variants
S. Liao, Y. He, J. Qu, Y. Shi, Y. Liu, K. Zhao, J. Chen, Y. Jing, C. K.-F. Shen, C. Ji, G. Luo, X. Zhao, S. Li, Y. Fan, Z. Lv, , L. Li
This paper develops equine polyclonal antibodies that broadly neutralize major SARS-CoV-2 variants, showing high efficacy in vitro and ex vivo with low cost and potential for large-scale production.
bioRxiv · Jul 27, 2022 · PreprintImmunology